US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% AAPL $333.69 ▲+1.02%
FinancialContent

Quest Diagnostics (NY:DGX)

233.33 +2.24 (+0.97%)
Official Closing Price Updated: 7:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Quest Diagnostics (NYSE:DGX) Breakout Setup Backed by Technical Rating 7 and Setup Rating 8 ↗
Via Chartmill
These S&P500 stocks have an unusual volume in today's session ↗
Via Chartmill
These S&P500 stocks are moving in today's session ↗
Via Chartmill
News headline image
Why Quest Diagnostics Holdings Stock Dropped Today ↗
The government thinks it's been overpaying Quest Diagnostics. They plan to stop doing that next year. 
Via The Motley Fool
Topics Regulatory Compliance
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Via Chartmill
Quest Diagnostics (NYSE:DGX) Shows Dividend Quality Beyond the Headline Yield ↗
Via Chartmill
Quest Diagnostics (NYSE:DGX) Surges After Crushing Q2 Estimates and Raising Guidance ↗
Via Chartmill
Quest Diagnostics (NYSE:DGX) Offers a Secure and Sustainable Dividend with Strong Profitability ↗
Via Chartmill
Quest Diagnostics Inc (NYSE:DGX): A Top Dividend Stock with Sustainable Income and Growth Potential ↗
Via Chartmill
Quest Diagnostics (NYSE:DGX): A Solid Dividend Play Backed by Strong Profitability and Financial Health ↗
Via Chartmill
Discover the top S&P500 movers in Tuesday's pre-market session. ↗
Via Chartmill
News headline image
Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges ↗
Quest Diagnostics (NYSE:DGX) CEO and President Jim Davis said the diagnostic testing company is exceeding the growth framework it outlined at its prior investor day, driven largely by organic growth,... 
Via MarketBeat
Discover which S&P500 stocks are making waves on Tuesday. ↗
Via Chartmill
News headline image
Quest Diagnostics CEO Sells 10,000 Shares for $2.4 Million ↗
J. E. Davis disposed of 8% of his direct equity stake under a pre-planned Rule 10b5-1 trading arrangement, retaining $28.9 million in company stock. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Why Quest Diagnostics Stock Climbed This Past Week ↗
Demand for medical testing services is rising. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Quest Diagnostics Q2 Earnings Call Highlights ↗
Quest Diagnostics (NYSE:DGX) reported double-digit revenue growth and raised its full-year 2026 outlook after what executives described as strong demand across its physician, hospital and consumer... 
Via MarketBeat
Topics Earnings
News headline image
Americans Are Buying More Preventive Health Tests—and Quest Diagnostics Is Winning ↗
Quest Diagnostics (NYSE: DGX) stock jumps after Q2 earnings beat estimates and full-year 2026 guidance gets a boost. 
Via Benzinga
Topics Earnings
Let's take a look at the S&P500 stocks that are experiencing unusual volume in today's session. ↗
Via Chartmill
What's going on in today's session: S&P500 movers ↗
Via Chartmill
Which S&P500 stocks are gapping on Thursday? ↗
Via Chartmill
News headline image
Transcript: Quest Diagnostics Q2 2026 Earnings Conference Call ↗
Quest Diagnostics (NYSE:DGX) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by... 
Via Benzinga
Topics Earnings
These S&P500 stocks that are showing activity before the opening bell on Thursday. ↗
Via Chartmill
News headline image
Quest’s (NYSE:DGX) Q2 CY2026: Beats On Revenue, Stock Soars
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) beat Wall Street’s revenue expectations in Q2 CY2026, with sales up 10.2% year on year to $3.04 b... 
Via StockStory
Top S&P500 movers in Friday's pre-market session ↗
Via Chartmill
News headline image
3 Reasons to Sell DGX and 1 Stock to Buy Instead
Since November 2025, Quest has been in a holding pattern, posting a small return of 2.6% while floating around $194.06. The stock also fell short of the S&P ... 
Via StockStory
Topics Stocks
News headline image
1 Profitable Stock to Own for Decades and 2 We Avoid
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does... 
Via StockStory
News headline image
2026 Market Cap Madness Championship: Loren v. Emily ↗
It’s time to crown a winner: defending champion Emily Flippen faces off against Cinderella challenger Loren Horst in the Market Cap Madness World Championship. 
Via The Motley Fool
News headline image
5 Must-Read Analyst Questions From Quest’s Q1 Earnings Call
Quest Diagnostics delivered first quarter results that exceeded Wall Street’s revenue and profit expectations, driven by broad-based demand for its clinical ... 
Via StockStory
Topics Artificial Intelligence Earnings
News headline image
DGX Q1 Deep Dive: Organic Growth, Consumer Testing Momentum, and Advanced Diagnostics Drive Outlook
Healthcare diagnostics company Quest Diagnostics (NYSE:DGX) reported Q1 CY2026 results topping the market’s revenue expectations, with sales up 9.2% year on ... 
Via StockStory
Topics Artificial Intelligence
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >